Edition:
India

Tocagen Inc (TOCA.OQ)

TOCA.OQ on NASDAQ Stock Exchange Global Select Market

10.33USD
24 Nov 2017
Change (% chg)

$0.22 (+2.18%)
Prev Close
$10.11
Open
$10.12
Day's High
$10.44
Day's Low
$10.09
Volume
25,112
Avg. Vol
36,993
52-wk High
$17.75
52-wk Low
$8.64

Select another date:

Thu, Nov 9 2017

BRIEF-Tocagen Q3 loss per share $0.50

* Tocagen reports third quarter 2017 financial and business results

BRIEF-Tocagen to accelerate Toca 511 & Toca FC development into Phase 3 trial

* Tocagen to accelerate Toca 511 & Toca FC development into pivotal Phase 3 trial Source text for Eikon: Further company coverage:

BRIEF-Tocagen Q2 loss per share $0.56

* Tocagen reports second quarter 2017 financial and business results

BRIEF-Tocagen reports quarterly loss per share $0.56‍​

* Qtrly license revenue $10,000 versus $13,000 Source text: (http://bit.ly/2wuNluv) Further company coverage:

BRIEF-Tocagen receives PRIME designation for Toca 511

* Tocagen receives European Medicines Agency Priority Medicines (PRIME) designation for Toca 511 in high grade Glioma Source text for Eikon: Further company coverage:

Select another date: